Murray Kimmel

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

Jerald Sadoff, Mathieu Le Gars, Georgi Shukarev et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

Veterinary Medicine, Infectious Diseases, Immunization +16

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

Carlos A. DiazGranados, Andrew J. Dunning, Murray Kimmel et al. · New England Journal of Medicine · 2014 · 867 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Michael G. Ison, Alberto Papi, Eugene Athan et al. · Clinical Infectious Diseases · 2024 · 162 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial

Jerald Sadoff, Mathieu Le Gars, Georgi Shukarev et al. · medRxiv · 2020 · 141 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study

Paul Goepfert, Bo Fu, Anne-Laure Chabanon et al. · The Lancet Infectious Diseases · 2021 · 123 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14